Last edition
News about Market
AstraZeneca Pharma India has launched K+ Connect, a nationwide initiative bringing together multidisciplinary experts from 33 healthcare centres to strengthen long-term hyperkalaemia management in patients with heart failure and chronic kidney disease.
Market | 14/05/2026 | By News Bureau
Shilpa Medicare Signs Long-Term Manufacturing and Development Pact with NXI Therapeutics AG
Shilpa Medicare and NXI Therapeutics AG have entered into a long-term agreement to support development and commercial manufacturing of immunomodulatory therapies, expanding Shilpa’s global CDMO footprint in high-growth biologics and specialty therapeutics.
Market | 14/05/2026 | By News Bureau
Bristol Myers Squibb and Hengrui Pharma collaborated to jointly develop 13 early-stage programmes across oncology, haematology and immunology, with a potential deal value of up to USD 15.2 billion.
Market | 13/05/2026 | By News Bureau
GSK Partners with Sino Biopharmaceutical to Accelerate Hepatitis B Therapy Launch in China
GSK and Sino Biopharmaceutical’s CTTQ have partnered to accelerate the launch of bepirovirsen in China, aiming to expand access to a potential first-in-class chronic hepatitis B therapy with functional cure potential.
Market | 12/05/2026 | By News Bureau
Daiichi Sankyo Unveils 5-Year Oncology Growth Strategy
Daiichi Sankyo launches a 5-year strategy targeting global oncology leadership, aiming for 2.3 trillion yen in oncology revenue by 2030 through new indications, breakthrough technologies, and expanded commercialisation capabilities.
Market | 12/05/2026 | By News Bureau | 102
Optum Rx Launches Industry's First Transparent Pharmacy Care Model
Optum Rx launches the industry’s first transparent pharmacy care model, improving drug pricing transparency, aligning incentives, and expanding affordability tools for patients and health plan sponsors.
Market | 12/05/2026 | By News Bureau
Hongene Biotech Supports SiranBio's Dual-Target siRNA Programme for Chronic Hepatitis B
Hongene Biotech provided end-to-end CDMO support for SiranBio’s SA1211 siRNA candidate, highlighting its capabilities in complex oligonucleotide therapeutic development and manufacturing.
Market | 11/05/2026 | By News Bureau
P&G Health Launches Neurobion Nerve Pain Relief Cream for Targeted Symptomatic Relief
P&G Health introduces a specialised topical cream with capsaicin and soothing ingredients to help manage nerve-related pain, tingling and burning sensations in hands and feet.<br />
Market | 08/05/2026 | By News Bureau
Merck Becomes Sole Testing Provider for FDA-Approved Gene Therapies of Genetix Biotherapeutics
Merck signs a 5-year deal as sole testing provider for Genetix Biotherapeutics’ gene therapies, delivering end-to-end testing to support safe, reliable commercialisation of advanced therapies.
Market | 08/05/2026 | By News Bureau
Neuland Laboratories partnership with LIR Life Sciences Corp will focus on developing and manufacturing cell-penetrating peptides to support LIR Life’s patch-based GLP-1/GIP obesity treatment platform.
Market | 07/05/2026 | By News Bureau | 113
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy